Parkside Financial Bank & Trust Bridge Bio Pharma, Inc. Transaction History
Parkside Financial Bank & Trust
- $976 Million
- Q3 2025
A detailed history of Parkside Financial Bank & Trust transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 84 shares of BBIO stock, worth $5,323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84
Previous 84
-0.0%
Holding current value
$5,323
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$789 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$588 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...